For the patients with single primary cancer, among 542 evaluable patients (those with both germline and somatic mutations which were in same or different genes), 25 patients (4.6%) had biallelic events, and the involved genes included ATM, BRCA1, BRCA2, BRIP1, and ERCC5. The gene discussed is BRCA2; the disease is cancer.